(Total Views: 145)
Posted On: 02/27/2024 9:20:35 AM
Post# of 103413
$VTAK Catheter Precision, Inc. (NYS American:VTAK) Announces Attendance at the International Symposium on Left Atrial Appendage
https://www.accesswire.com/836529/catheter-pr...-appendage
FORT MILL, SC / ACCESSWIRE / February 26, 2024 / Catheter Precision, Inc. (the "Company"
(NYSE American:VTAK), a US based medical device company focused on novel electrophysiology products, announced that the Company is showcasing their LockeT suture closure device at the International Symposium on Left Atrial Appendage. The annual ISLAA conference is taking place at the Intercontinental New York Times Square in New York City from March 1 - 2, 2024.
Catheter Precision's CEO, David Jenkins, said, "Last week VTAK announced that the initial clinical data on LockeT was shared at the Western Atrial Fibrillation Symposium with great response from physicians and industry. Last week's meeting focused on advancements in Atrial Fibrillation, but this ISLAA will focus on the Left Atrial Appendage (LAA) and expands the audience to all cardiovascular physicians. LockeT's use in LAA procedures enables the benefits of our closure device to go beyond electrophysiology procedures."
The ISLAA conference is an internationally recognized meeting focused on educating physicians, nurses and allied health professionals in the fields of electrophysiology, cardiology, family and internal medicine about the Left Atrial Appendage (LAA). Educational sessions are led by world-renowned faculty and the symposium will offer very informative presentations on the anatomy, physiology and pathological aspect of the LAA, along with old and new therapeutic strategies of stroke prophylaxis including cardiac devices for LAA exclusion.
https://www.accesswire.com/836529/catheter-pr...-appendage
FORT MILL, SC / ACCESSWIRE / February 26, 2024 / Catheter Precision, Inc. (the "Company"
(NYSE American:VTAK), a US based medical device company focused on novel electrophysiology products, announced that the Company is showcasing their LockeT suture closure device at the International Symposium on Left Atrial Appendage. The annual ISLAA conference is taking place at the Intercontinental New York Times Square in New York City from March 1 - 2, 2024. Catheter Precision's CEO, David Jenkins, said, "Last week VTAK announced that the initial clinical data on LockeT was shared at the Western Atrial Fibrillation Symposium with great response from physicians and industry. Last week's meeting focused on advancements in Atrial Fibrillation, but this ISLAA will focus on the Left Atrial Appendage (LAA) and expands the audience to all cardiovascular physicians. LockeT's use in LAA procedures enables the benefits of our closure device to go beyond electrophysiology procedures."
The ISLAA conference is an internationally recognized meeting focused on educating physicians, nurses and allied health professionals in the fields of electrophysiology, cardiology, family and internal medicine about the Left Atrial Appendage (LAA). Educational sessions are led by world-renowned faculty and the symposium will offer very informative presentations on the anatomy, physiology and pathological aspect of the LAA, along with old and new therapeutic strategies of stroke prophylaxis including cardiac devices for LAA exclusion.
(0)
(0)Scroll down for more posts ▼
